⚪image loading
(from DailyMed)

Pseudoephedrine Hydrochloride 120 mg Tablet, Extended Release, 10-count — NDC 62011-0306-1 (Billing 62011-0306-01)

by STRATEGIC SOURCING SERVICES LLC · 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of 10 tablets of Pseudoephedrine Hydrochloride 120 mg Tablet, Extended Release from STRATEGIC SOURCING SERVICES LLC, no longer marketed (first marketed Feb 2017), no longer in the FDA NDC Directory; retail pharmacies pay about $0.2756 per tablet (NADAC). It is this product's only package size.

NDC 62011-0306-01
🏷️ FDA NDC (as labeled) 62011-0306-1 billing pads the package segment with a zero
OTC Generic Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Nov 19, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 62011-0306-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
62011 labeler · 0306 product · 1 package
Package marketed since
Feb 20, 2017
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
10 EA per package
Barcode (UPC-A, from the NDC)
3 6201103061 3
FDA record last changed
Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Dec 2024. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 62011-0306-1
Product NDC 62011-0306
11-digit billing NDC 62011030601
NCPDP billing unit EA — each (per item)
RxCUI 1049154
UNII 6V9V2RYJ8N
Application # ANDA077442
SPL Set ID 918b2a90-532b-4358-bdff-9ad48c167a7e
Established class (EPC) alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Dec 2024)
Marketing start 2017-02-20
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance PSEUDOEPHEDRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 42101020107405
GPI class HM Nasal Decongestant 12 Hour
GCN Seq No 016937
GCN 26901
HICL code 002091
Ingredient (HICL) Pseudoephedrine Hcl
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B6
Therapeutic class — intermediate (HIC2) Drugs Affecting The Trachea And Bronchi (Cont3)
HIC3 code B6V
Therapeutic class — specific (HIC3) Decongestants, Oral
AHFS code 12:12.12.00
AHFS class Alpha- And Beta-Adrenergic Agonists
FDB label name HM NASAL DECONGEST ER 120 MG
FDB brand name Nasal Decongestant
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 016937
  • GCN: 26901
  • GPI-14 (Medi-Span): 42101020107405
  • HICL (First Databank): 002091
  • AHFS class code: 12:12.12.00
  • RxCUI (RxNorm): 1049154
Why two NDCs? The FDA registers this code as 62011-0306-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 62011-0306-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the alpha-Adrenergic Agonist class.

Pharmacologic class alpha-Adrenergic Agonist
Drug family (ATC) Sympathomimetics
How it works Adrenergic alpha-Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name HM NASAL DECONGEST ER 120 MG Ingredient Pseudoephedrine Hcl
📖 What it is MedlinePlus · NLM

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Most products also relieve sinus congestion and pressure. It treats s...
  • It depends on the product. Regular tablets and softgels are repeated every 4 to 6 hours, 12-hour tablets about every 12 hours, and a 24-hour tablet once a day. Check your label for...
  • No. Swallow them whole with water and don't divide, crush, chew or dissolve them. You may see the tablet in your stool, and the label says that's normal.
  • Can I crush or chew extended-release pseudoephedrine tablets?
📖 Read our full Pseudoephedrine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.276 $2.76 / 10 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jul 2022 Oct 2023 Jun 2024 Feb 2025 $0.313 $0.252
▼ Down 11% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
62011-0306-01 You're viewing this Main listing 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK 2017-02-20 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pseudoephedrine Hydrochloride 120 mgthis 62011-0306-01 STRATEGIC 10 tablets $0.276 — Discontinued —
leader 12 hour nasal decongestant 120 mg 70000-0475-01 Cardinal 1 tablet $0.276 — FDA listed +0%
Good Sense Suphedrine 12 Hour 120 mg 00113-0054-52 L. 1 tablet $0.285 — Availability likely +3%
sinus 12 hour 120 mg 00113-2017-60 L. 1 tablet $0.285 — Availability likely +3%
SudoGest 12 Hour 120 mg 00904-6754-15 Major 1 tablet $0.285 — Availability likely +3%
Pseudoephedrine hydrochloride 120 mg 00904-7409-15 Major 10 tablets $0.285 — Availability likely +3%
good neighbor pharmacy nasal decongestant 120 mg 24385-0054-52 Amerisource 1 tablet $0.285 — Availability likely +3%
pseudoephedrine hydrochloride 120 mg 45802-0107-52 Padagis 1 tablet $0.285 — Availability likely +3%
Pseudoephedrine hydrochloride 120 mg 51660-0204-21 Ohm 20 tablets $0.285 — Availability likely +3%
Pseudoephedrine hydrochloride 120 mg 51660-0492-21 Ohm 20 tablets $0.285 — Availability likely +3%
Pseudoephedrine Hydrochloride 120 mg 70000-0601-01 CARDINAL 20 tablets $0.285 — Availability likely +3%
12 Hour Nasal Decongestant 120 mg 70000-0656-01 CARDINAL 10 tablets $0.285 — Availability likely +3%
nasal decongestant 120 mg 70677-0001-01 Strategic 10 tablets $0.285 — Discontinued +3%
Pseudoephedrine hydrochloride 120 mg 70677-1019-01 STRATEGIC 10 tablets $0.285 — Availability likely +3%
Nasal Decongestant D 120 mg 00363-3301-52 Walgreen 1 tablet — — FDA listed —
sinus pressure and congestion relief maximum strength 120 mg 11822-0650-06 Rite 1 tablet — — FDA listed —
Pseudoephedrine HCl 120 mg 21130-0158-67 Better 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 21130-0204-21 Safeway 20 tablets — — Discontinued —
Pseudoephedrine hydrochloride 120 mg 30142-0967-20 The 20 tablets — — FDA listed —
topcare 12 hour decongestant 120 mg 36800-0054-52 Topco 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 37808-0007-69 HEB 20 tablets — — FDA listed —
Equaline 12 Hour Decongestant 120 mg 41163-0054-60 United 1 tablet — — FDA listed —
nasal decongestant 120 mg 41250-0809-52 Meijer 1 tablet — — FDA listed —
CareOne Nasal and Sinus Decongestant 120 mg 41520-0429-52 American 1 tablet — — FDA listed —
equate sinus 12 hour 120 mg 49035-0508-60 Wal-Mart 1 tablet — — FDA listed —
Sudafed Sinus Congestion 12 Hour 120 mg 50090-4629-00 A-S 10 tablets — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 50090-5554-00 A-S 10 tablets — — FDA listed —
Sudafed Sinus Congestion 12 Hour 120 mg 50580-0242-01 Kenvue 10 tablets — — FDA listed —
sinus and nasal decongestant 120 mg 51316-0616-52 CVS 1 tablet — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 53943-0204-10 DISCOUNT 10 tablets — — Discontinued —
nasal decongestant 120 mg 56062-0054-60 Publix 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 56062-0204-21 Publix 20 tablets — — FDA listed —
Pseudoephedrine HCl 120 mg 58602-0804-67 Aurohealth 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 59779-0204-21 CVS 20 tablets — — Discontinued —
12 Hour Nasal Decongestant 120 mg 59779-0703-52 CVS 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 63868-0143-10 Chain 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 68016-0204-69 Chain 10 tablets — — Discontinued —
Pseudoephedrine hydrochloride 120 mg 68196-0204-20 SAM'S 10 tablets — — FDA listed —
Leader 12 Hour Sinus Nasal Decongestant 120 mg 70000-0735-01 Cardinal 1 tablet — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 85766-0050-10 Sportpharm 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 00363-0204-20 Walgreen 20 tablets — — FDA listed —
nasal decongestant 120 mg 42507-0054-52 HyVee 1 tablet — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
Listed with the FDA since
Feb 2017
📍
2026
Currently FDA-listed
9 years listed
🔓
·
This is a generic
listed with the FDA
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Pseudoephedrine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSTRATEGIC SOURCING SERVICES LLC
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA077442 (ANDA)
Labeler code62011
First marketedFeb 2017
Product typeHuman Otc Drug
Portfolio317 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 25 words ▾

Uses • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies • temporarily relieves sinus congestion and pressure

⏱️ Dosage and Administration 42 words ▾

Directions adults and children 12 years and over • take 1 tablet every 12 hours • do not take more than 2 tablets in 24 hours children under 12 years do not use this product in children under 12 years of age

⚠️ Warnings 152 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • trouble urinating due to an enlarged prostate gland When using this product do not exceed recommended dosage Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • symptoms do not improve within 7 days or occur with a fever If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📦 Storage and Handling 34 words ▾

Other information • store at 59° to 77° F in a dry place. Protect from light • TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.

🧪 Active Ingredient 10 words ▾

Active ingredient (in each tablet) Pseudoephedrine HCl, USP 120 mg

🧪 Inactive Ingredients 14 words ▾

Inactive ingredients castor oil, colloidal silicon dioxide, hypromellose, microcrystalline cellulose, magnesium stearate, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Nasal decongestant

📄 Do Not Use 55 words ▾

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • trouble urinating due to an enlarged prostate gland

📄 When Using This Product 9 words ▾

When using this product do not exceed recommended dosage

📄 Stop Use and Ask a Doctor If 26 words ▾

Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • symptoms do not improve within 7 days or occur with a fever

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📄 Questions or Comments 3 words ▾

Questions? call 1-800-406-7984

📄 Package Label / Principal Display Panel 64 words ▾

PRINCIPAL DISPLAY PANEL - 120 mg Tablet Blister Pack Carton NDC 62011-0306-1 Health Mart ® Compare to Sudafed ® 12 Hour active ingredient* MAXIMUM STRENGTH Nasal Decongestant Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, USP Long-Acting Nasal Decongestant 12 Hour • Non-Drowsy SINUS PRESSURE + CONGESTION ACTUAL SIZE 10 Coated Capsule-Shaped Tablets 120 mg Each PRINCIPAL DISPLAY PANEL - 120 mg Tablet Blister Pack Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pseudoephedrine Hydrochloride — the ingredient across all brands.

Top reported reactions

Pain6,379
Fatigue6,340
Abdominal Discomfort5,499
Systemic Lupus Erythematosus5,387
Rheumatoid Arthritis5,340
Rash5,334
Pemphigus5,231

Age at onset

Neonate80
Infant8
Child110
Adolescent82
Adult3,991
Elderly1,962

Reporter sex

36,729 reports
Male · 27%
Female · 73%
Unknown · 0%

Serious outcomes

Hospitalization9,866
Disabling5,402
Death5,177
Life-threatening4,457
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 3,614 1,530
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
STRATEGIC SOURCING SERVICES LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.